 | • レポートコード：TPM-B05038 • 出版社/出版日：Transparency Market Research / 2018年4月24日 • レポート形態：英文、PDF、274ページ • 納品方法：Eメール • 産業分類：Healthcare |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、呼吸器関連機器の世界市場について調べ、呼吸器関連機器の世界規模、市場動向、市場環境、製品タイプ別（治療機器、診断・モニタリング機器）分析、用途別（慢性閉塞性肺疾患、喘息、閉塞型睡眠時無呼吸症候群、呼吸窮迫症候群、嚢胞性線維症、肺炎）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、バリューチェーン分析、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・呼吸器関連機器の世界市場動向 ・呼吸器関連機器の世界市場環境 ・呼吸器関連機器のバリューチェーン分析 ・呼吸器関連機器の世界市場規模 ・呼吸器関連機器の世界市場規模：製品タイプ別（治療機器、診断・モニタリング機器） ・呼吸器関連機器の世界市場規模：用途別（慢性閉塞性肺疾患、喘息、閉塞型睡眠時無呼吸症候群、呼吸窮迫症候群、嚢胞性線維症、肺炎） ・呼吸器関連機器の世界市場：地域別市場規模・分析 ・呼吸器関連機器の北米市場規模・予測 ・呼吸器関連機器のアメリカ市場規模・予測 ・呼吸器関連機器の中南米市場規模・予測 ・呼吸器関連機器のヨーロッパ市場規模・予測 ・呼吸器関連機器のアジア市場規模・予測 ・呼吸器関連機器の日本市場規模・予測 ・呼吸器関連機器の中国市場規模・予測 ・呼吸器関連機器のインド市場規模・予測 ・呼吸器関連機器の中東市場規模・予測 ・呼吸器関連機器のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Respiratory Devices Market: Overview
Respiratory devices are medical equipment that assist patients with respiration in a critical care situation. Additionally, respiratory devices are used to deliver medicines to treat several respiratory diseases. Moreover, these devices are used to diagnose respiratory problems in patients. Increase in incidence of COPD and sleep apnea, strategic alliance between key players, and rise in government expenditure are the major factors projected to propel the global respiratory devices market during the forecast period. However, high cost of respiratory devices and uncertain and ambiguous regulatory environment hamper the growth of the market.
The report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, application, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global respiratory devices market.
Global Respiratory Devices Market: Key Segments
In terms of product type, the global respiratory devices market has been segmented into therapeutic devices and diagnostic & monitoring devices. The therapeutic devices segment has been classified into drug delivery devices, mechanical ventilators, continuous positive airway pressure, resuscitators, humidifiers, airway clearance devices, oxygen concentrators, consumables & disposables, and others. The diagnostic & monitoring devices segment has been categorized into pulse oximeters, capnographs, spirometers, polysomnographs, peak flow meters, gas analyzers, and others. Based on application, the market has been divided into chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis, and pneumonia. The global respiratory devices market has been analyzed based on increasing cases of respiratory diseases, technology trends, expenditure on emerging technology, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Respiratory Devices Market: Regional Outlook
Geographically, the global respiratory devices market has been segmented into five major regions and the key countries in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the report are ResMed, Inc., Smiths Medical, Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, GE Healthcare, Getinge AB, Medtronic plc, Koninklijke Philips N.V., Chart Industries, and Vyaire Medical, Inc.
The global respiratory devices market has been segmented as follows:
Global Respiratory Devices Market, by Product Type
Therapeutic Devices
Diagnostic & Monitoring Devices
Global Respiratory Devices Market, by Therapeutic Devices
Drug Delivery Devices
Nebulizers
Inhalers
Mechanical Ventilators
Invasive
Non-Invasive
Continuous Positive Airway Pressure
Devices
Disposables
Resuscitators
Reusable
Disposables
Humidifiers
Airway Clearance Devices
Oxygen Concentrators
Consumables & Disposables
Others
Global Respiratory Devices Market, by Diagnostic & Monitoring Devices
Pulse Oximeters
Capnographs
Spirometers
Polysomnographs
Peak Flow Meters
Gas Analyzers
Others
Global Respiratory Devices Market, by Application
Chronic Obstructive Pulmonary Disease
Asthma
Obstructive Sleep Apnea
Respiratory Distress Syndrome
Cystic Fibrosis
Pneumonia
Global Respiratory Devices Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Respiratory Devices Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Global Respiratory Devices Market Analysis and Forecasts, 2016–2026
4.3.1. Market Revenue Projections (US$ Mn)
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.3.4. Key Trends
5. Market Outlook
5.1. Value Chain Analysis
5.2. Regulatory Framework
5.3. Porter’s Five Force Analysis
6. Global Respiratory Devices Market Analysis and Forecasts, by Product Type
6.1. Introduction & Definition
6.2. Market Value Forecast, by Product Type, 2016–2026
6.2.1. Therapeutic Devices
6.2.2. Diagnostic & Monitoring Devices
6.3. Market Attractiveness Analysis
6.3.1. Therapeutic Devices
6.3.2. Diagnostic & Monitoring Devices
7. Global Respiratory Devices Market Analysis and Forecasts, by Therapeutic Devices
7.1. Introduction & Definition
7.2. Market Value Forecast, by Therapeutic Devices, 2016–2026
7.2.1. Drug Delivery Devices
7.2.1.1. Nebulizers
7.2.1.2. Inhalers
7.2.2. Mechanical Ventilators
7.2.2.1. Invasive
7.2.2.2. Non-Invasive
7.2.3. Continuous Positive Airway Pressure (CPAP)
7.2.3.1. Devices
7.2.3.2. Disposables
7.2.4. Resuscitators
7.2.4.1. Reusable
7.2.4.2. Disposables
7.2.5. Humidifiers
7.2.6. Airway Clearance Devices
7.2.7. Oxygen Concentrators
7.2.8. Consumables & Disposables
7.2.9. Others
7.3. Market Attractiveness by Therapeutic Devices
7.3.1. Drug Delivery Devices
7.3.2. Mechanical Ventilators
7.3.3. Continuous Positive Airway Pressure (CPAP)
7.3.4. Resuscitators
7.3.5. Humidifiers
7.3.6. Airway Clearance Devices
7.3.7. Oxygen Concentrators
7.3.8. Consumables & Disposables
7.3.9. Others
8. Global Respiratory Devices Market Analysis and Forecasts, by Diagnostic & Monitoring Devices
8.1. Introduction & Definition
8.2. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
8.2.1. Pulse Oximeters
8.2.2. Capnographs
8.2.3. Spirometers
8.2.4. Polysomnographs (PSG)
8.2.5. Peak Flow Meters
8.2.6. Gas Analyzers
8.2.7. Others
8.3. Market Attractiveness, by Diagnostic & Monitoring Devices
8.3.1. Pulse Oximeters
8.3.2. Capnographs
8.3.3. Spirometers
8.3.4. Polysomnographs (PSG)
8.3.5. Peak Flow Meters
8.3.6. Gas Analyzers
8.3.7. Others
9. Global Respiratory Devices Market Analysis and Forecasts, by Application
9.1. Introduction & Definition
9.2. Market Value Forecast, by Application, 2016–2026
9.2.1. Chronic Obstructive Pulmonary Disease (COPD)
9.2.2. Asthma
9.2.3. Obstructive Sleep Apnea (OSA)
9.2.4. Respiratory Distress Syndrome (RDS)
9.2.5. Cystic Fibrosis
9.2.6. Pneumonia
9.3. Market Attractiveness, by Application
9.3.1. Chronic Obstructive Pulmonary Disease (COPD)
9.3.2. Asthma
9.3.3. Obstructive Sleep Apnea (OSA)
9.3.4. Respiratory Distress Syndrome (RDS)
9.3.5. Cystic Fibrosis
9.3.6. Pneumonia
10. Global Respiratory Devices Market Analysis and Forecasts, by Region
10.1. Market Value Share Analysis, by Region
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
11. North America Respiratory Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2016–2026
11.2.1. Therapeutic Devices
11.2.2. Diagnostic & Monitoring Devices
11.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
11.3.1. Drug Delivery Devices
11.3.1.1. Nebulizers
11.3.1.2. Inhalers
11.3.2. Mechanical Ventilators
11.3.2.1. Invasive
11.3.2.2. Non-Invasive
11.3.3. Continuous Positive Airway Pressure (CPAP)
11.3.3.1. Devices
11.3.3.2. Disposables
11.3.4. Resuscitators
11.3.4.1. Reusable
11.3.4.2. Disposables
11.3.5. Humidifiers
11.3.6. Airway Clearance Devices
11.3.7. Oxygen Concentrators
11.3.8. Consumables & Disposables
11.3.9. Others
11.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
11.4.1. Pulse Oximeters
11.4.2. Capnographs
11.4.3. Spirometers
11.4.4. Polysomnographs (PSG)
11.4.5. Peak Flow Meters
11.4.6. Gas Analyzers
11.4.7. Others
11.5. Market Value Forecast, by Application, 2016–2026
11.5.1. Chronic Obstructive Pulmonary Disease (COPD)
11.5.2. Asthma
11.5.3. Obstructive Sleep Apnea (OSA)
11.5.4. Respiratory Distress Syndrome (RDS)
11.5.5. Cystic Fibrosis
11.5.6. Pneumonia
11.6. Market Value Forecast, by Country, 2016–2026
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Therapeutic Devices
11.7.2. By Diagnostic & Monitoring Devices
11.7.3. By Application
11.7.4. By Country
12. Europe Respiratory Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2016–2026
12.2.1. Therapeutic Devices
12.2.2. Diagnostic & Monitoring Devices
12.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
12.3.1. Drug Delivery Devices
12.3.1.1. Nebulizers
12.3.1.2. Inhalers
12.3.2. Mechanical Ventilators
12.3.2.1. Invasive
12.3.2.2. Non-invasive
12.3.3. Continuous Positive Airway Pressure (CPAP)
12.3.3.1. Devices
12.3.3.2. Disposables
12.3.4. Resuscitators
12.3.4.1. Reusable
12.3.4.2. Disposables
12.3.5. Humidifiers
12.3.6. Airway Clearance Devices
12.3.7. Oxygen Concentrators
12.3.8. Consumables & Disposables
12.3.9. Others
12.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
12.4.1. Pulse Oximeters
12.4.2. Capnographs
12.4.3. Spirometers
12.4.4. Polysomnographs (PSG)
12.4.5. Peak Flow Meters
12.4.6. Gas Analyzers
12.4.7. Others
12.5. Market Value Forecast, by Application, 2016–2026
12.5.1. Chronic Obstructive Pulmonary Disease (COPD)
12.5.2. Asthma
12.5.3. Obstructive Sleep Apnea (OSA)
12.5.4. Respiratory Distress Syndrome (RDS)
12.5.5. Cystic Fibrosis
12.5.6. Pneumonia
12.6. Market Value Forecast, by Country / Sub-region, 2016–2026
12.6.1. Germany
12.6.2. France
12.6.3. U.K.
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Therapeutic Devices
12.7.2. By Diagnostic & Monitoring Devices
12.7.3. By Application
12.7.4. By Country/Sub-region
13. Asia Pacific Respiratory Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2016–2026
13.2.1. Therapeutic Devices
13.2.2. Diagnostic & Monitoring Devices
13.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
13.3.1. Drug Delivery Devices
13.3.1.1. Nebulizers
13.3.1.2. Inhalers
13.3.2. Mechanical Ventilators
13.3.2.1. Invasive
13.3.2.2. Non-Invasive
13.3.3. Continuous Positive Airway Pressure (CPAP)
13.3.3.1. Devices
13.3.3.2. Disposables
13.3.4. Resuscitators
13.3.4.1. Reusable
13.3.4.2. Disposables
13.3.5. Humidifiers
13.3.6. Airway Clearance Devices
13.3.7. Oxygen Concentrators
13.3.8. Consumables & Disposables
13.3.9. Others
13.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
13.4.1. Pulse Oximeters
13.4.2. Capnographs
13.4.3. Spirometers
13.4.4. Polysomnographs (PSG)
13.4.5. Peak Flow Meters
13.4.6. Gas Analyzers
13.4.7. Others
13.5. Market Value Forecast, by Application, 2016–2026
13.5.1. Chronic Obstructive Pulmonary Disease (COPD)
13.5.2. Asthma
13.5.3. Obstructive Sleep Apnea (OSA)
13.5.4. Respiratory Distress Syndrome (RDS)
13.5.5. Cystic Fibrosis
13.5.6. Pneumonia
13.6. Market Value Forecast, by Country/Sub-region, 2016–2026
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of APAC
13.7. Market Attractiveness Analysis
13.7.1. By Therapeutic Devices
13.7.2. By Diagnostic & Monitoring Devices
13.7.3. By Application
13.7.4. By Country/Sub-region
14. Latin America Respiratory Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2016–2026
14.2.1. Therapeutic Devices
14.2.2. Diagnostic & Monitoring Devices
14.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
14.3.1. Drug Delivery Devices
14.3.1.1. Nebulizers
14.3.1.2. Inhalers
14.3.2. Mechanical Ventilators
14.3.2.1. Invasive
14.3.2.2. Non-Invasive
14.3.3. Continuous Positive Airway Pressure (CPAP)
14.3.3.1. Devices
14.3.3.2. Disposables
14.3.4. Resuscitators
14.3.4.1. Reusable
14.3.4.2. Disposables
14.3.5. Humidifiers
14.3.6. Airway Clearance Devices
14.3.7. Oxygen Concentrators
14.3.8. Consumables & Disposables
14.3.9. Others
14.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
14.4.1. Pulse Oximeters
14.4.2. Capnographs
14.4.3. Spirometers
14.4.4. Polysomnographs (PSG)
14.4.5. Peak Flow Meters
14.4.6. Gas Analyzers
14.4.7. Others
14.5. Market Value Forecast, by Application, 2016–2026
14.5.1. Chronic Obstructive Pulmonary Disease (COPD)
14.5.2. Asthma
14.5.3. Obstructive Sleep Apnea (OSA)
14.5.4. Respiratory Distress Syndrome (RDS)
14.5.5. Cystic Fibrosis
14.5.6. Pneumonia
14.6. Market Value Forecast, by Country/Sub-region, 2016–2026
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of LATAM
14.7. Market Attractiveness Analysis
14.7.1. By Therapeutic Devices
14.7.2. By Diagnostic & Monitoring Devices
14.7.3. By Application
14.7.4. By Country / Sub-region
15. Middle East & Africa Respiratory Devices Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2016–2026
15.2.1. Therapeutic Devices
15.2.2. Diagnostic & Monitoring Devices
15.3. Market Value Forecast, by Therapeutic Devices, 2016–2026
15.3.1. Drug Delivery Devices
15.3.1.1. Nebulizers
15.3.1.2. Inhalers
15.3.2. Mechanical Ventilators
15.3.2.1. Invasive
15.3.2.2. Non-Invasive
15.3.3. Continuous Positive Airway Pressure (CPAP)
15.3.3.1. Devices
15.3.3.2. Disposables
15.3.4. Resuscitators
15.3.4.1. Reusable
15.3.4.2. Disposables
15.3.5. Humidifiers
15.3.6. Airway Clearance Devices
15.3.7. Oxygen Concentrators
15.3.8. Consumables & Disposables
15.3.9. Others
15.4. Market Value Forecast, by Diagnostic & Monitoring Devices, 2016–2026
15.4.1. Pulse Oximeters
15.4.2. Capnographs
15.4.3. Spirometers
15.4.4. Polysomnographs (PSG)
15.4.5. Peak Flow Meters
15.4.6. Gas Analyzers
15.4.7. Others
15.5. Market Value Forecast, by Application, 2016–2026
15.5.1. Chronic Obstructive Pulmonary Disease (COPD)
15.5.2. Asthma
15.5.3. Obstructive Sleep Apnea (OSA)
15.5.4. Respiratory Distress Syndrome (RDS)
15.5.5. Cystic Fibrosis
15.5.6. Pneumonia
15.6. Market Value Forecast, by Country/Sub-region, 2016–2026
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Israel
15.6.4. Rest of MEA
15.7. Market Attractiveness Analysis
15.7.1. By Therapeutic Devices
15.7.2. By Diagnostic & Monitoring Devices
15.7.3. By Application
15.7.4. By Country / Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. ResMed Inc.
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. SWOT Analysis
16.2.1.5. Strategic Overview
16.2.2. Smiths Medical (part of Smiths Group plc)
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2..2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. SWOT Analysis
16.2.2.5. Strategic Overview
16.2.3. Fisher & Paykel Healthcare Limited
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3..2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. SWOT Analysis
16.2.3.5. Strategic Overview
16.2.4. Dragerwerk AG & Co. KGaA
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4..2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. SWOT Analysis
16.2.4.5. Strategic Overview
16.2.5. GE Healthcare (part of General Electric Company)
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5..2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. SWOT Analysis
16.2.5.5. Strategic Overview
16.2.6. Getinge AB
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6..2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. SWOT Analysis
16.2.6.5. Strategic Overview
16.2.7. Medtronic plc
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7..2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. SWOT Analysis
16.2.7.5. Strategic Overview
16.2.8. Koninklijke Philips N.V.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8..2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. SWOT Analysis
16.2.8.5. Strategic Overview
16.2.9. Chart Industries
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9..2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. SWOT Analysis
16.2.9.5. Strategic Overview
16.2.10. ResMed Inc.
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. SWOT Analysis
16.2.10.5. Strategic Overview
16.2.11. Vyaire Medical Inc. (Becton, Dickinson and Company)
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Financial Overview
16.2.11.3. Product Portfolio
16.2.11.4. SWOT Analysis
16.2.11.5. Strategic Overview
Table 01: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 02: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Device Type, 2016–2026
Table 03: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 04: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 05: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by CPAP, 2016–2026
Table 06: Global Therapeutic Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 07: Global Diagnostic & Monitoring Respiratory Devices Market Size (US$ Mn) Forecast, by Device Type, 2016–2026
Table 08: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 09: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 10: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 11: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 12: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Device, 2016–2026
Table 13: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilator, 2016–2026
Table 14: North America Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 15: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitator, 2016–2026
Table 16: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 17: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 19: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 20: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Device, 2016–2026
Table 21: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 22: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 23: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 24: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Devices, 2016–2026
Table 25: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 26: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 27: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 28: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 29: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 30: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 31: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 32: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 33: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 34: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 35: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 36: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 37: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 38: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 39: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 40: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 41: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 42: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 43: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices Type, 2016–2026
Table 44: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Drug Delivery Devices, 2016–2026
Table 45: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Mechanical Ventilators, 2016–2026
Table 46: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by C-PAP, 2016–2026
Table 47: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Resuscitators, 2016–2026
Table 48: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostics & Monitoring Type, 2016–2026
Table 49: MEA Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2016–2026